Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
NBIX
NBIX News & Events
-
Add to Watchlist
Trade NBIX
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
NBIX News
FDA Grants Orphan Drug Designation to Neurocrine's NBIB-223
3d ago
seekingalpha
First Expert Recommendations for Glucocorticoid Dose Reduction Published
4d ago
PRnewswire
New Algorithms Aid in Reducing Hormone Doses for CAH Patients
4d ago
Newsfilter
Neurocrine Biosciences Reports Record Q1 2026 Earnings Driven by INGREZZA
4d ago
seekingalpha
Neurocrine Biosciences Q1 Earnings Exceed Expectations
5d ago
seekingalpha
Investigation Alerts for Multiple Company Mergers
5d ago
Globenewswire
Neurocrine Biosciences Q1 Earnings Announcement Scheduled
6d ago
seekingalpha
Neurocrine Biosciences Releases Survey Findings on Tardive Dyskinesia Impact
6d ago
PRnewswire
Show More News
NBIX Events
05/07 12:00
Neurocrine Biosciences Granted FDA Orphan Designation
Neurocrine Biosciences was granted FDA orphan designation for a treatment of Friedreich ataxia, according to a post to the agency's website.
Show More Events
NBIX Monitor News
Neurocrine Biosciences Publishes Expert Recommendations for Glucocorticoid Dose Reduction
May 06 2026
Neurocrine Biosciences Reports Q4 Earnings Miss Amid Strong Sales Growth
Feb 12 2026
Neurocrine Highlights INGREZZA Efficacy
Nov 26 2025
NBIX Earnings Analysis
Neurocrine Biosciences Q3 2025: Earnings & Strategic Growth- Intellectia AI™
6 months ago
People Also Watch
